{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:13:36Z","timestamp":1755036816290},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Non-AT-III mediated heparin-resistance during CPB occurs by complex-forming with heparin-binding proteins. Currently, there are no specific recommendations for non-AT-III mediated heparin-resistance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present a fatal case of a 70-yr-old male-patient undergoing cardiac-surgery in which refractory heparin-resistance was observed. The massive AL amyloidosis found at autopsy is thought to be responsible and illustrates that awareness and knowledge of the etiology and perioperative strategies of non-AT-III mediated heparin-resistance is important.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For anticoagulation during cardiopulmonary bypass surgery in case of a non-AT-III medicated heparin resistance, we refer to the decision tree added to this manuscript and if necessary to consider direct thrombin inhibitors, such as bivalirudin or argatroban, as it bypasses the complexing pathway.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12871-023-02147-4","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T12:02:20Z","timestamp":1687348940000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heparin-resistance in AL amyloidosis: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Elisabeth S.","family":"van Ede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlijn P. A.","family":"Hoeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera D.","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toin H.","family":"van Kuppevelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elly M.","family":"Versteeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo G.","family":"Hafmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjan","family":"Diepstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benno","family":"Kusters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanne M. M.","family":"Vermorgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"issue":"6","key":"2147_CR1","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1213\/ANE.0b013e31827e4e62","volume":"116","author":"A Finley","year":"2013","unstructured":"Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013;116(6):1210\u201322.","journal-title":"Anesth Analg"},{"issue":"3","key":"2147_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0950-3536(05)80017-4","volume":"3","author":"B Boneu","year":"1990","unstructured":"Boneu B, Caranobe C, Sie P. Pharmacokinetics of heparin and low molecular weight heparin. Baillieres Clin Hematol. 1990;3(3):531\u201344.","journal-title":"Baillieres Clin Hematol"},{"issue":"27","key":"2147_CR3","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.1039\/C7OB01058C","volume":"15","author":"RJ Weiss","year":"2017","unstructured":"Weiss RJ, Esko JD, Tor Y. Targeting heparin and heparan sulfate protein interactions. Org Biomol Chem. 2017;15(27):5656\u201368.","journal-title":"Org Biomol Chem"},{"issue":"6","key":"2147_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.0954-6820.1967.tb07991.x","volume":"181","author":"J Christiansen","year":"1967","unstructured":"Christiansen J, Lindqvist B. Heparin-resistance in amyloidosis. Acta Med Scand. 1967;181(6):723\u20134.","journal-title":"Acta Med Scand"},{"issue":"110","key":"2147_CR5","doi-asserted-by":"publisher","first-page":"0589","DOI":"10.1098\/rsif.2015.0589","volume":"12","author":"MCZ Meneghetti","year":"2015","unstructured":"Meneghetti MCZ, Hughes AJ, Rudd TR, et al. Heparan sulfate and heparin interactions with proteins. J R Soc Interface. 2015;12(110):0589.","journal-title":"J R Soc Interface"},{"key":"2147_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/bs.ircmb.2016.02.009","volume":"325","author":"J-P Li","year":"2016","unstructured":"Li J-P, Kusche-Gullberg M. Heparan Sulfate: Biosynthesis, Structure, and Function. Int Rev Cell Mol Biol. 2016;325:215\u201373.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"5","key":"2147_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2559.1994.tb00551.x","volume":"24","author":"J Moss","year":"1994","unstructured":"Moss J, Shore I, Woodrow D. AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin. Histopathology. 1994;24(5):427\u201335.","journal-title":"Histopathology."},{"issue":"10","key":"2147_CR8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1177\/39.10.1940305","volume":"39","author":"AD Snow","year":"1991","unstructured":"Snow AD, Bramson R, Mar H, Wight TN, Kisilevsky R. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem. 1991;39(10):1321\u201330.","journal-title":"J Histochem Cytochem"},{"issue":"5","key":"2147_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1365-3083.1991.tb01584.x","volume":"34","author":"T Stenstad","year":"1991","unstructured":"Stenstad T, Magnus JH, Kolset SO, Cornwell GG 3rd, Husby G. Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin. Scand J Immunol. 1991;34(5):611\u20137.","journal-title":"Scand J Immunol"},{"issue":"6","key":"2147_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1053\/j.ajkd.2006.03.036","volume":"47","author":"C Sucker","year":"2006","unstructured":"Sucker C, Hetzel GR, Grabensee B, Stockschlaeder M, Scharf RE. Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis. 2006;47(6):947\u201355.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2147_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.athoracsur.2017.09.061","volume":"105","author":"L Shore-Lesserson","year":"2018","unstructured":"Shore-Lesserson L, Baker RA, Ferraris VA, et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass. Ann Thorac Surg. 2018;105(2):650\u201362.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"2147_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0267659115583525","volume":"31","author":"E McNair","year":"2016","unstructured":"McNair E, Marcoux JA, Bally C, Gamble J, Thomson D. Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery. Perfusion. 2016;31(3):189\u201399.","journal-title":"Perfusion"},{"issue":"2","key":"2147_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijcard.2010.02.044","volume":"148","author":"L R\u00f6ssig","year":"2011","unstructured":"R\u00f6ssig L, Genth-Zotz S, Rau M, Heyndrickx GR, Schneider T, Gulba DC, Desaga M, Buerke M, Harder S, Zeiher AM, ARG-E04 study group. Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study. Int J Cardiol. 2011;148(2):214\u20139.","journal-title":"Int J Cardiol."},{"issue":"9","key":"2147_CR14","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1097\/CCM.0000000000005033","volume":"49","author":"TG Seelhammer","year":"2021","unstructured":"Seelhammer TG, Bohman JK, Schulte PJ, Hanson AC, Aganga DO. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation. Crit Care Med. 2021;49(9):1481\u201392.","journal-title":"Crit Care Med"},{"issue":"2","key":"2147_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/ALN.0000000000001976","volume":"128","author":"A Koster","year":"2018","unstructured":"Koster A, Faraoni D, Levy JH. Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery. Anesthesiology. 2018;128(2):390\u2013400.","journal-title":"Anesthesiology"},{"issue":"2","key":"2147_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0609.2006.00786.x","volume":"78","author":"ME Martin","year":"2007","unstructured":"Martin ME, Kloecker GH, Laber DA. Argatroban for anticoagulation during cardiac surgery. Eur J Haematol. 2007;78(2):161\u20136.","journal-title":"Eur J Haematol"},{"issue":"5","key":"2147_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.ejcts.2008.07.035","volume":"34","author":"AI Smith","year":"2008","unstructured":"Smith AI, Stroud R, Damiani P, Vaynblat M. Use of Argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy. Eur J Cardiothorac Surg. 2008;34(5):1113\u20134.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2147_CR18","unstructured":"Argatroban injection. Center for drug evaluation and research, Department of health and human services; https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2016\/203049Orig1s004.pdf. Accessed Feb 2016."}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02147-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-023-02147-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02147-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T12:56:52Z","timestamp":1702645012000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-023-02147-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2147"],"URL":"https:\/\/doi.org\/10.1186\/s12871-023-02147-4","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"assertion":[{"value":"31 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish was obtained from the patients\u2019 relative.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}